Home >  Registry
     
 
 Protocol Registry Trial Results IFPMA Background Links
About this Registry

This registry serves as a global repository for information on ongoing Roche Pharmaceuticals Phase II to Phase IV clinical studies, Phase I studies in patients and Roche Diagnostics interventional studies on advanced diagnostic products.

For More Information 

Common Questions
More Frequently Asked Questions 
Overview of Clinical Trials 
Glossary of Terms 
Phase Definitions 
Field Definitions 
Roche Clinical Trial Global Policy 
Site Provided by Thomson CenterWatch

Colorectal Cancer

  • A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer.
    Recruiting


  • A Study of Avastin (Bevacizumab) in Patients With Newly Diagnosed Locally Advanced Rectal Cancer.
    Recruiting


  • A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.
    Recruiting


  • OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
    Recruiting


  • A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer.
    Recruiting


  • A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
    Recruiting


  • A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.
    Recruiting


  • A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer
    Recruiting


  • A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.
    No longer recruiting


  • A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.
    No longer recruiting


  • A Study of Avastin (Bevacizumab) and Oxalplatin Plus Xeloda (Capacitabine) in Patients With Advanced Colorectal Cancer.
    No longer recruiting


  • A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
    No longer recruiting


  • A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
    No longer recruiting


  • A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.
    No longer recruiting


  • A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
    No longer recruiting


  • A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
    No longer recruiting


  • A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
    No longer recruiting


  • A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
    No longer recruiting


  • A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
    No longer recruiting


  • SOCRATES Study - A Study of Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer
    No longer recruiting


  • A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
    No longer recruiting


  • A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.
    No longer recruiting


  • A Study of the Efficacy and Tolerability of Xeloda (Capecitabine) in First-Line and Second-Line Therapy in Patients With Metastatic Colorectal Cancer
    Completed


  • A Study of Xeloda (Capecitabine) Combined With Standard Radiotherapy in Patients With Locally Advanced Rectal Cancer
    Completed


  • A Study of Xeloda (Capecitabine) in the Adjuvant Treatment of Patients With Resected Colon Cancer
    Completed


  • A Study of Xeloda (Capecitabine) in Combination Chemotherapy With Eloxatin (Oxaliplatin) Plus Pelvic Irradiation Before Surgery for Rectal Cancer
    Completed


  • A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
    Completed


  • A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
    Completed


  • A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
    Completed


  • A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
    Completed


  • A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
    Completed


  • A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
    Completed


  • A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
    Completed


  • A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.
    Completed


  • A Study of Xeloda (Capecitabine) Plus Radiotherapy in Patients With Rectal Cancer
    Completed


  • A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
    Completed


  • A Dose-Finding Study of Tarceva (Erlotinib) in Combination Chemotherapy for Metastatic Colorectal Cancer.
    Completed


  • A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.
    Terminated


    		•

    © 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement